Small molecules inhibit growth, viability and ergosterol biosynthesis in Candida albicans

SpringerPlus

Volumn 2, Issue 1, 2013, Pages 1-6

  Rajput, Sandeep B ^a   Mohan Karuppayil, S ^a  

^a SWAMI RAMANAND TEERTH MARATHWADA UNIVERSITY   (India)

Author keywords

Antifungals; Candida albicans; Ergosterol biosynthesis; Small molecules

Indexed keywords

EID: 84876513962     PISSN: None     EISSN: 21931801     Source Type: Journal    
DOI: 10.1186/2193-1801-2-26     Document Type: Article

References (19)

1. Ahmad A, Khan A, Manzoor N, Khan LA (2010) Evolution of ergosterol biosynthesis inhibitors as fungicidal against Candida. Microb Pathog 48:35-41
2. Ahmed A, Khan A, Akhtar F, Yousuf S, Xess I, Khan A, Manzoor N (2011) Fungicidal activity of thymol and carvacrol by disrupting ergosterol biosynthesis and membrane integrity against Candida. Eur J Clin Microbiol Infect Dis 30:41-50
3. Arthington-Skaggs BA, Jradi H, Desai T, Morrison CJ (1999) Quantification of ergosterol content: Novel method for determination of Fluconazole susceptibility of Candida albicans. J Clin Microbiol 37:3332-3337
4. Berman J, Sudbery PE (2002) Candida albicans: a molecular revolution built on lessons from budding yeast. Nat Rev Genet 3(12):918-30
5. Cannon RD, Lamping E, Holmes AR, Niimi K, Baret PV, Keniya MV, Tanabe K, Niimi M, Goffeau A, Monk BC (2009) Efflux-mediated antifungal drug resistance. Clin Microbiol Rev 22:291-321
6. Cowan MM (1999) Plant products as antimicrobial agents. Clin Microbiol Rev 12:564-582
7. Devkatte AN, Zore GB, Karuppayil SM (2005) Potential of plant oils as inhibitors of Candida albicans growth. FEMS Yeast Res 5:867-873
8. Gupta AK, Tomas E (2003) New antifungal agents. Dermatol Clin 21:565-76
9. Kaleli I, Cevahir N, Demir M, Yildirim U, Sahin R (2007) Anti-Candidal activity of Pseudomonas aeruginosa strains isolated from clinical specimens. Mycoses 50:74-78
10. Maschmeyer G (2006) The changing epidemiology of invasive fungal infections: new threats. Int J Antimicrob Agents 27(1):3-6
11. Michal T, Klaus PL (2009) Potentilla-a review of its phytochemical and pharmacological profile. J Ethnopharmacol 122:184-204
12. Navarro-Martinez MD, Garcia-Canovas F, Rodriguez-Lopez JN (2006) Tea polyphenol epigallocatechin-3-gallate inhibits ergosterol synthesis by disturbing folic acid metabolism in Candida albicans. J Antimicrob Chemother 57:1083-92
13. Odds FC, Brown AJ, Gow NA (2003) Antifungal agents: Mechanisms of action. Trends Microbiol 11(6):272-279
14. Rajput SB, Karuppayil SM (2012) β-asarone, an active principle of Acorus calamus rhizome, inhibit morphogenesis, biofilm formation and ergosterol biosynthesis in Candida albicans. Phytomed, http://dx.doi.org/10.1016/j. phymed.2012.09.029
15. Sanglard D, Ischer F, Parkinson T, Falconer D, Bille J (2003) Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents. Antimicrob Agents Chemother 47:2404-12
16. Sheikh S, Bhatia R, Khan R, Muralidhar S, Basir SF, Manzoor N, Khan LA (2011) Exposure of Candida to p-anisaldehyde inhibits its growth and ergosterol biosynthesis. J Gen Appl Microbiol 57:129-136
17. Uribe S, Ramirez J, Pena A (1985) Effect of β-pinene on yeast membrane functions. J Bacteriol 161(3):1195-1200
18. Zore GB, Thakre AD, Rathod V, Karuppayil SM (2010) Evaluation of anti-Candida potential of geranium oil constituents against clinical isolates of Candida albicans differentially sensitive to fluconazole: inhibition of growth, dimorphism and sensitization. Mycoses 54:99-109
19. Zore GB, Thakre AD, Jadhav S, Karuppayil SM (2011) Terpenoids inhibit Candida albicans growth by affecting membrane integrity and arrest of cell cycle. Phytomed 18:1181-1190